Gainers

  • Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares moved upwards by 40.95% to $0.31. The market value of their outstanding shares is at $12.3 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 28.54% to $1.07.
  • Turn Therapeutics (NASDAQ:TTRX) shares moved upwards by 25.61% to $12.31. The market value of their outstanding shares is at $297.6 million.
  • Roivant Sciences (NASDAQ:ROIV) stock increased by 19.86% to $41.87. The market value of their outstanding shares is at $25.2 billion.
  • Actinium Pharmaceuticals (AMEX:ATNM) stock rose 18.33% to $1.22. The company's market cap stands at $32.3 million.

Losers

  • Lexaria Bioscience (NASDAQ:LEXX) shares decreased by 35.5% to $9.12 during Tuesday's regular session. The market value of their outstanding shares is at $23.3 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock declined by 33.98% to $10.08. The company's market cap stands at $9.1 million.
  • GRI Bio (NASDAQ:GRI) shares fell 29.52% to $2.03. The market value of their outstanding shares is at $6.2 million.
  • Jaguar Health (NASDAQ:JAGX) stock decreased by 24.2% to $0.45. The company's market cap stands at $3.0 million.
  • Gelteq (NASDAQ:GELS) stock fell 22.11% to $0.7. The market value of their outstanding shares is at $9.6 million.
  • Atrium Therapeutics (NASDAQ:RNA) stock fell 20.58% to $11.27. The market value of their outstanding shares is at $242.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.